Allozymes' innovative method of quickly testing millions of enzyme variations per day using microfluidics is reshaping the biotech industry by providing a valuable dataset for AI and attracting investors.
The company's growth from less than five people to 32 across multiple locations with expanded lab space showcases the scalability and impact of its enzyme-screening technology in accelerating the discovery process.
Traditional enzyme testing methods are limited in throughput, but Allozymes' approach allows millions of enzymes to be tested daily through a high-speed microfluidics system, revolutionizing the speed and efficiency of enzyme discovery.
[
add
]
[
|
|
...
]